搜索临床试验以:NSCLC, TNBC, hormone receptor positive (HR ) breast cancer, recurrent epithelial ovarian cancer, UC,
总计113868个结果
-
OSI Pharmaceuticals完全的
-
National Taiwan University HospitalNational Science Council, Taiwan未知
-
Tampere UniversityFinnish Prostate Cancer Group未知
-
Brooke Army Medical CenterGlaxoSmithKline; Becton, Dickinson and Company完全的
-
Yankton Clinical Research AllianceUniversity of South Dakota; Yankton Medical Clinic; Avera Sacred Heart Hospital未知
-
Robert Wood Johnson FoundationAventis Pharmaceuticals完全的
-
Baskent University完全的
-
Diabetica Solutions Inc.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
MANTA 1 Study Italian Collaborative GroupBristol-Myers Squibb未知
-
Savient PharmaceuticalsNeurologic AIDS Research Consortium (NARC)终止
-
Leiden University Medical CenterGlaxoSmithKline; Academisch Ziekenhuis Groningen; Netherlands Organisation for Scientific Research 和其他合作者终止
-
University of California, San Francisco终止
-
Regional Hospital Holstebro完全的
-
University of OsloNorwegian Institute of Public Health; Ullevaal University Hospital; Hormone Laboratory, Aker University... 和其他合作者未知
-
VaxGenNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health... 和其他合作者完全的
-
National Cancer Institute, MilanAssociazione Italiana per la Ricerca sul Cancro完全的
-
Rambam Health Care CampusRoche Pharma AG未知
-
The University of Texas Health Science Center at...Novartis完全的
-
Rennes University HospitalMinistry of Health, France终止
-
Sociedad Española de Neumología y Cirugía Torácica未知
-
Daiichi Sankyo, Inc.完全的
-
Poitiers University HospitalNovartis完全的
-
Rennes University HospitalWyeth is now a wholly owned subsidiary of Pfizer; Bayer; Farmades, Italy终止